Clinical Trial Update: D-Cycloserine Augmentation of Therapy for Pediatric Obsessive-Compulsive Disorder [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating D-Cycloserine as augmentation to therapy for pediatric obsessive-compulsive disorder has completed, with results posted in 2012.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obsessive-compulsive Disorder

Drugs mentioned

• D-cycloserine (D-cycloserine)

Snippet

Sponsor: University of South Florida | Conditions: Obsessive-compulsive Disorder | Phase 2 | Status: COMPLETED | Results posted: 2012-10-17